Navigation Links
Metabolex Appoints Donald Hill as Chief Financial Officer
Date:4/14/2008

HAYWARD, Calif., April 14 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced today that Donald M. Hill has joined the company as chief financial officer. Mr. Hill brings extensive financial and strategic planning experience to Metabolex, including expertise in business development, treasury management and controllership of large operating divisions. Mr. Hill joins Metabolex following more than 20 years in finance and corporate development management roles at Merck & Co., Inc., most recently as Assistant Treasurer, Global Capital Markets.

"The appointment of Don expands the depth of our already strong management team," said President and Chief Executive Officer Harold Van Wart, Ph.D. "Don's experience as a leader in a well respected, financially sophisticated pharmaceutical company, his experience in business development, and his strong analytical skills and strategic financial vision will be critical for us as we expand our product pipeline and move our clinical product candidates towards commercialization. With the company's four clinical product candidates and active discovery and preclinical development programs, Don's skills in financial planning and strategic product development will be invaluable."

Mr. Hill is a Chartered Financial Analyst (CFA), and holds a B.A. from the University of California, Berkeley and a Masters degree from the Sloan School of Management at the Massachusetts Institute of Technology.

About Metabolex

Metabolex is a privately-held biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, with an emphasis on type 2 diabetes. Metabolex has drawn on its deep understanding of diabetes to create a large database of genes involved in diabetes and to build a rich pipeline of product candidates and drug di
'/>"/>

SOURCE Metabolex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biopure Appoints New Independent Auditor
2. Indivumed Appoints Annette Kassen as Vice President Clinical Research
3. ADVENTRX Appoints Vice President of Manufacturing
4. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
5. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
6. Observant LLC Appoints Two New Directors to the Senior Management Team
7. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
8. Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
9. IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors
10. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
11. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...FRANCISCO, Dec. 1 Medizo...announced today that in tests involving its propri...break "6 log" decontamination barriers, this time ...austridium difficile and Bacillis subtilis. These ...tremely potent sporicidal technology. "The implica...
(Date:12/1/2009)... DNA Genotek, a leading provider of produc...ed that Tepnel Pharmaceutical Services will offer ... its nucleic acid extraction and genotyping servic...ecember 1, 2009 -- DNA Genotek , a leading provid...oday announced that Tepnel Pharmaceutical Service...
(Date:12/1/2009)... iCardiac now provides services to three o..., Rochester, NY (PRWEB) De...lobal leader in advanced cardiac core lab services...pharmaceutical company has selected iCardiac as a ...ac will provide Highly Automated QT(sm) and Dynami...
(Date:11/30/2009)...MBUS, Ohio, Nov. 30 The Ohio Capit...he nation,s first minority business early-stage ca... December 3, is called "Transforming the Landscape...-Stage Capital Summit." It will feature several sp...ness leaders and local minority entrepreneurs. ,...
Breaking Biology Technology:Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
...16 Epeius Biotechnologies,Corporation, a leader i...ed,two additional European patents for the platfor...t enable precision gene delivery to primary cancer...ut the body. With profound,demonstrations of clini...overall safety, Epeius Biotech continues to lead t...
...R) (zolpidem tartrate sublingual lozenge) as the f...ment of middle-of-the-night awakenings , , PT...cals, Inc., a privately-held specialty pharmaceuti...confirmation from the U.S. Food and Drug Administr...r Intermezzo (R) (zolpidem tartrate sublingual lo...
...6 Cardium Therapeutics (NYSE Alternext US: CXM) a...oday announced enrollment of the first patient in ...g conducted by researchers at the University of C...nnerCool,s new UroCool(TM), a pelvic catheter syst...otic-assisted prostatectomy surgery. , , (Log...
Other Biology Technology:Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 2Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 3Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 4Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R) 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 2Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 3Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 4Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 5Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 6Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 7Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study 8
(Date:12/1/2009)...e Yerkes National Primate Research Center, Emory U...ransgenic prairie voles, an important step toward ...e future application of this technology will enabl...tions that will help identify the brain mechanisms...ors. This advancement may also have important impl...
(Date:12/1/2009)...NYVALE, Calif., Dec. 1 GestureTek ...se 3.0 - a turnkey, portable, plug and play intera...xhibits, entertainment and touring promotions. Ges...tents in camera-enabled gesture recognition techno...ertainment systems. ,, Guaranteed for quality, ...
(Date:12/1/2009)...available in German . , Brown adipose tissue ...s of mitochondria, miniature power stations which... they normally generate a voltage similar to that ...lar processes. However, the mitochondria of brown ... ahead all the time. The energy released when the ...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Brown fat cells make 'spare tires' shrink 2VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Mesa Labs Reports Higher First Quarter Earnings 54256 1Mesa Labs Reports Higher First Quarter Earnings 54256 2Mesa Labs Reports Higher First Quarter Earnings 54256 3Mesa Labs Reports Higher First Quarter Earnings 54256 4Mesa Labs Reports Higher First Quarter Earnings 54256 5Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
...ported this week in the online early edition of th..., finds that coal burning, primarily in North Ame...tially affected human health and ecosystems in and...d "Coal Burning Leaves Toxic Heavy Metal Legacy in... Institute (DRI), Reno, Nev. and partially funded ...
...orate product offerings and international distribu...outh Africa and neighboring ...RX Inc., (OTC,Bulletin Board: BMRX), today announc...idiary of Sequiam Corporation have been transferre... creditor, Biometric Investors LLC,(BIL). bioMETRX...
...-- The National Science Foundation,s Expeditions i... Molecular Programming Project, a collaborative ef... Technology and the University of Washington to es...mplex molecular and chemical systems based on the ...heir study, molecular programs, are collections of...
Other Biology News:Greenland ice core reveals history of pollution in the Arctic 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 3Caltech researchers awarded $10M for molecular programming project 2
Ban II from Roche Applied Science
Eco RII (Bst NI) from Roche Applied Science
Xho I from Roche Applied Science
...The CpGenome Fast DNA Modification Kit contains re...n on a DNA sample. In the bisulfite reaction, all ...ed, converting them to uracils, while 5-methylcyto...treated DNA will differ depending on whether the D...
Biology Products: